What does Morphocell Technologies do?
Regenerative medicine company developing stem cell-derived tissue and organ replacement therapies for liver disease using iPSC-derived platform technology, with operations in Montreal, Cambridge and Toronto
Explore Morphocell Technologies careers and hiring status. Find jobs at Morphocell Technologies and official application links when roles are open. Funding stage: Series A. Headcount: 11-50. Regenerative medicine company developing stem cell-derived tissue and organ replacement therapies for liver disease using iPSC-derived platform technology, with operations in Montreal, Cambridge and Toronto
This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.
Morphocell Technologies is a Series A stage AI startup, founded in 2018, with $50M in total disclosed funding. Its most recent round was a $10M Series A in Dec 2025. It has no open roles listed at the moment; new Morphocell Technologies openings are tracked daily. Source: Fast AI Jobs company dataset, updated Sep 2026.
Company profile last updated on Aug 27, 2026.
Morphocell Technologies careers and hiring status: no open roles are currently listed here, but you can review the company profile and check the official career page for the latest openings. Official careers page
Morphocell Technologies is an biotech company. Regenerative medicine company developing stem cell-derived tissue and organ replacement therapies for liver disease using iPSC-derived platform technology, with operations in Montreal, Cambridge and Toronto
Open positions
Check the official career page, browse adjacent companies, or subscribe for new openings.
Candidate questions
Regenerative medicine company developing stem cell-derived tissue and organ replacement therapies for liver disease using iPSC-derived platform technology, with operations in Montreal, Cambridge and Toronto
Morphocell Technologies does not have open roles listed on our platform right now. Visit the official company website or career page for the latest openings, or subscribe to get notified when new roles are posted.
Morphocell Technologies has raised $50M in total. The latest known stage is Series A.
Morphocell Technologies reports an employee count of 11-50.
Morphocell Technologies was founded in 2018.
Morphocell Technologies is associated with Biotech, Healthcare, Manufacturing, B2B SaaS, Analytics, Infrastructure.
Company context
Morphocell Technologies is a Series A stage AI startup, founded in 2018, with $50M in total disclosed funding. Its most recent round was a $10M Series A in Dec 2025. It has no open roles listed at the moment; new Morphocell Technologies openings are tracked daily. Source: Fast AI Jobs company dataset, updated Sep 2026.